Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-001067

Chief Financial Officer sold 1,000 shares at $234.04 ($234,040)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Brett Chief Financial Officer 2025-01-08 Sale 10b5-1 −1,000 $234.04 $234,040 92,864 D
Open-market sales · 1,000 sh · avg $234.04 · $234,040
Loading xslF345X05/form4.xml…